Evidence map›Paper›PMID 22491340›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131.

Young Ah Kim, Zubair A Qureshi, Jennifer M Adams-Haduch, Yoon Soo Park, Kathleen A Shutt, Yohei Doi

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. International Epidemiology of Carbapenemase-Producing Escherichia coli.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Emergence of a ClinicalFrontiers in microbiology · 2020
    Article
  7. Article
  8. Article
  9. Diversity among blaScientific reports · 2018
    Article
  10. Article
  11. Draft Genome Sequences ofGenome announcements · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Young Ah KimDivision of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.
Zubair A Qureshi
Jennifer M Adams-Haduch
Yoon Soo Park
Kathleen A Shutt
Yohei Doi
University of Pittsburgh Medical Center · USNational Health Insurance Service · KR

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Multidrug-Resistant Acinetobacter baumanniiK22AI080584 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2009 to 2010
$269k
Epidemiology of Community-Associated, ESBL-Producing Escherichia coliR03AI079296 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2009 to 2010
$167k
NCATS NIH HHS UL1 TR000005NCRR NIH HHS UL1 RR024153NIAID NIH HHS K22 AI080584NIAID NIH HHS K22AI080584NIAID NIH HHS R03 AI079296NIAID NIH HHS R03AI079296
6 · The paper itself

Abstract

backgroundKlebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae has become endemic in many US hospitals. On the other hand, KPC-producing Escherichia coli remains rare.

methodsWe studied infection or colonization due to KPC-producing E. coli identified at our hospital between September 2008 and February 2011. A case-control study was conducted to document clinical features associated with this organism. Susceptibility testing, sequencing of β-lactamase genes, pulsed-field gel electrophoresis, multilocus sequence typing, and plasmid analysis were performed for characterization of the isolates.

resultsThirteen patients with KPC-producing E. coli were identified. The patients had multiple comorbid conditions and were in hospital for variable periods of time before KPC-producing E. coli was identified. The presence of liver diseases was independently associated with recovery of KPC-producing E. coli when compared with extended-spectrum β-lactamase-producing E. coli. The isolates showed variable susceptibility to carbapenems. Seven isolates belonged to sequence type (ST) 131, which is the international epidemic, multidrug-resistant clone, but their plasmid profiles were diverse. KPC-producing organisms other than E. coli were isolated within 1 month from 5 of the patients. The KPC-encoding plasmids were highly related in 3 of them, suggesting the occurrence of their interspecies transfer.

conclusionsKPC-producing E. coli infections occur in severely ill patients who are admitted to the hospital. Acquisition of the KPC-encoding plasmids by the ST 131 clone, reported here for the first time to our knowledge in the United States, seems to represent multiple independent events. These plasmids are often shared between E. coli and other species.

Indexed as

Multilocus Sequence TypingAdultAgedAged, 80 and overBacterial Proteinsbeta-LactamasesCase-Control StudiesCluster AnalysisCross InfectionElectrophoresis, Gel, Pulsed-FieldEscherichia coliEscherichia coli InfectionsFemaleGenotypeHumansMaleBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID22491340
PMCPMC3491773
OpenAlexW2111752046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.